推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled …

[HTML] from thelancet.comL Gianni, U Dafni, RD Gelber, E Azambuja… - The Lancet …, 2011 - Elsevier
The HERA trial is an international, multicentre, randomised, open-label, phase 3 trial comparing
treatment with trastuzumab for 1 and 2 years with observation after standard neoadjuvant, adjuvant
chemotherapy, or both in patients with HER2-positive early breast cancer. The primary ...
Cited by 7 - Related articles - All 7 versions

DNA Mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy

[HTML] from oxfordjournals.orgFA Sinicrope, NR Foster… - Journal of the …, 2011 - jnci.oxfordjournals.org
Methods We included stage II and III colon carcinoma patients (n = 2141) who were treated in
randomized trials of 5-FU-based adjuvant therapy. Tumors were analyzed for microsatellite instability
by polymerase chain reaction and/or for MMR protein expression by ...
Cited by 1 - Related articles - All 5 versions

Long‐term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin‐C alone as adjuvant treatment for non‐muscle‐invasive bladder …

R Colombo, A Salonia, Z Leib… - BJU …, 2011 - Wiley Online Library
Microwave-induced hyperthermia and mitomycin C is a device-assisted approach used to treat
non-muscle invasive bladder cancer (NMIBC) either in the adjuvant (prophylactic) set-up or in
an ablative regimen. Until recently, around 20 different studies have been published with ...
Cited by 5 - Related articles - All 9 versions

Failure to Adhere to Protocol Specified Radiation Therapy Guidelines was Associated with Decreased Survival in RTOG 9704--A Phase III Trial of Adjuvant …

RA Abrams, KA Winter, WF Regine… - International Journal of …, 2011 - Elsevier
RT was scored for 416 patients: 216 PP and 200 <PP. For all pancreatic sites (head,
body/tail) median survival (MS) for PP vs. <PP was 1.74 vs. 1.46 years (log–rank p =
0.0077). In multivariate analysis, PP vs. <PP score correlated more strongly with MS than ...
Cited by 1 - Related articles - All 3 versions

… Versus Weekly Doxorubicin and Daily Oral Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor As Neoadjuvant Therapy for Inflammatory and Locally …

[HTML] from ascopubs.orgGK Ellis, WE Barlow, JR Gralow… - Journal of Clinical …, 2011 - jco.ascopubs.org
... cooperative groups, specifically the North Central Cancer Treatment Group (NCCTG), Cancer
and Leukemia Group B (CALGB), Eastern Cooperative Oncology Group (ECOG), National Surgical
Adjuvant Breast and Bowel Project (NSABP), Radiation Therapy Oncology Group ...
Related articles - All 7 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451